Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03460522
Title Inotuzumab Ozogamicin and Conventional Chemotherapy In Patients Aged 56 Years and Older With ALL
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Nicola Goekbuget
Age Groups: adult | senior
Covered Countries DEU

No variant requirements are available.